Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Il-17 And Glutamte Excitotoxicity In The Pathogenesis Of Multiple Sclerosis.
Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.
Control of IL-17 receptor signaling and tissue inflammation by the p38α-MKP-1 signaling axis in a mouse model of multiple sclerosis.
Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.
Development of Activity-Related Muscle Fatigue during Robot-Mediated Upper Limb Rehabilitation Training in Persons with Multiple Sclerosis: A Pilot Trial.
Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
The insulin-like growth factor system in multiple sclerosis.
Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis.
Redox-based regulation of neural stem cell function and Nrf2.
Fulminant Demyelinating Diseases of the Central Nervous System.
Regulation of DM-20 mRNA expression and intracellular translocation of glutathione-S-transferase pi isoform during oligodendrocyte differentiation in the adult rat spinal cord.
Multiple sclerosis and the blood-central nervous system barrier.
Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis.
Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course.
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.
Relevance of Spinal Cord Abnormalities to Clinical Disability in Multiple Sclerosis: MR Imaging Findings in a Large Cohort of Patients.
Tackling autoimmunity with gene therapy.
Noise in multiple sclerosis: unwanted and necessary.
Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.
Interactions and tradeoffs between cell recruitment, proliferation, and differentiation affect CNS regeneration.
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
The membrane attack complex of complement causes severe demyelination associated with acute axonal injury.
A manic episode with psychotic features improved by methylprednisolone in a patient with multiple sclerosis.
Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Aggressive Multiple Sclerosis - whom, when and how.
Pages
« first
‹ previous
…
375
376
377
378
379
380
381
382
383
…
next ›
last »